Fen Huang

机构：Nanfang Hospital, Guangdong Provincial Center for Disease Control and Prevention, Southern Medical University

发表论文 16 篇 · 总被引 29 次 · h-index 4

代表论文

• Vedolizumab plus basiliximab as second-line therapy for steroid-refractory lower gastrointestinal acute graft-versus-host disease (2024 · Frontiers in Immunology · 被引 7)
• The safety and performance of the Spectra Optia apheresis system platelet depletion protocol in patients with elevated platelet counts (2022 · Journal of Clinical Apheresis · 被引 6)
• Olverembatinib (HQP1351)-based therapy in adults with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia in blast phase: results from a real-world study (2025 · Frontiers in Immunology · 被引 5)
• A prophylactic tyrosine kinase inhibitor strategy based on measurable residual disease pre‐transplantation for Ph + acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation: A prospective multicenter cohort study (2024 · American Journal of Hematology · 被引 4)
• China Expert consensus on the application of metagenomic next-generation sequencing for the etiological diagnosis of infections in hematological disorders (2024) (2025 · Blood Science · 被引 3)
• Safety and performance of the S pectra O ptia apheresis system for white blood cell depletion in patients with elevated white blood cell counts (2023 · Journal of Clinical Apheresis · 被引 3)